HOME >> BIOLOGY >> NEWS
Gene Shears In Cutting Edge Anti-Aids Trial

CSIRO's revolutionary "gene shears" technology has entered clinical trials in adults as the first step in developing a potential treatment for the human immunodeficiency virus (HIV) which causes AIDS, the chief executive of Gene Shears Pty Ltd, Dr Leigh Farrell announced today.

The Phase One clinical trial, conducted at St Vincent's Hospital, Sydney, is testing the safety and ability of Gene Shears' patented gene therapy to inhibit HIV replication in infected patients.

HIV attacks a special class of white blood cell, the CD4+ lymphocyte, which forms the backbone of the human immune defence against attacks by infection. Loss of these white blood cells causes the immune system eventually to break down.

The basis for the trial is the original discovery by CSIRO Plant Industry molecular biologists Dr Jim Haseloff and Dr Wayne Gerlach that naturally-occurring enzymes called ribozymes (dubbed "gene shears") can be used selectively to chop up pieces of genetic material. Gene Shears Pty Ltd went on to prove in laboratory experiments that ribozymesit could be used to prevent the replication of HIV by cutting its genetic material.

The chief executive of CSIRO, Dr Malcolm McIntosh, welcomed news that human trials of the anti-HIV gene shears were under way. "It is extremely pleasing that this fundamental Australian discovery is now starting to bear fruit in the form of practical applications which promise to improve human health and wellbeing," he said.

"It highlights the national importance of CSIRO continuing to perform excellent basic science designed to gain new knowledge."

The Sydney experiment involves six pairs of identical twins, of whom one of each pair is HIV-positive.

CD4+ white blood cells taken from the uninfected twin are equipped with the anti-HIV ribozyme and then infused into the HIV-infected twin.

The trial seeks first to establish that the ribozyme is safe and has no side-effects on the patien
'"/>

Contact: Dr Leigh Farrell
genes@ozemail.com.au
61-2-9878-8200
CSIRO Australia
4-Aug-1997


Page: 1 2

Related biology news :

1. Cutting-edge cancer researchers sought for international recognition
2. Cutting back on cigarettes: when less is more
3. AChemS: Cutting edge research in taste, smell, & chemical irritation
4. Cutting edge
5. Cutting-edge research to be presented at ASCPT pharmacology conference
6. Cutting the risk of coronary disease - start before birth says UK doctor
7. Story Tips: Engineering Students Pursue Cutting-Edge Research
8. Brain Building May Depend On DNA Cutting And Pasting
9. Cutting The Time And Cost Of Developing New Cures: Lord Sainsbury Launches Worlds First Biomedical Accelerator Mass Spectrometer In York
10. Flexibility In Cutting Toxic Releases Yields Dividends
11. Trial shows which brain cancer patients benefit from temozolomide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/4/2020)... ... 04, 2020 , ... Vitamin Science, Inc, a manufacturer of ... nutraceutical formula for ocular blue light protection. , VisiVite Blue Light Basher ... retina’s healthy pigmentation and improve the eye’s management of high energy blue light. ...
(Date:3/3/2020)... ... 2020 , ... Amplify Surgical, Inc., today announces that the company reached the ... , The landmark case was performed by Dr. Ali Najafi at Fresno Heart ... has completely changed the game for expandable interbodies. The ability to achieve an ...
(Date:3/2/2020)... , ... March 02, 2020 , ... Nominations are now ... co-founded by the Security Industry Association (SIA) and SecureIDNews and ... Women in Security Forum . The recipients of this year’s Women in Biometrics Awards ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... ... February 03, 2020 , ... ... Firm Travel, Law Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. ... Each Index illustrates the following statistics:, Average airfare ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... exclusive distributor to food and beverage manufactures within North America. Both Lifecycle and ... This agreement will allow each company to pool their collective resources and provide ...
(Date:1/28/2020)... STATE COLLEGE, Pa. (PRWEB) , ... January 28, ... ... trusted line of Better Salivary Assay Kits . The new Salivary ... salivary bioscience research. “By measuring total immunoglobulin G in saliva, researchers can extend ...
(Date:1/27/2020)... ... 27, 2020 , ... Valencell, the leading innovator in wearable ... by Halma plc , a FTSE 100 global group of life-saving technology ... WSJ Joshua Fund. A representative from Halma will join the Valencell board of ...
Breaking Biology Technology:
Cached News: